Vivo Capital, LLC Q3 2024 Filing
Filed November 13, 2024
Portfolio Value
$1.2T
Holdings
43
Report Date
Q3 2024
Filing Type
13F-HR
All Holdings (43 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 6,291,851 | $317.7B | 26.29% | |
| 2 | GONGeron Corp | 27,225,292 | $123.6B | 10.23% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $104.2B | 8.63% | |
| 4 | VRNAVerona Pharma PLC | 3,549,758 | $102.1B | 8.45% | |
| 5 | SVASinovac Biotech Ltd. | 11,800,000 | $76.3B | 6.32% | |
| 6 | TERNTerns Pharmaceuticals Inc | 6,895,746 | $57.5B | 4.76% | |
| 7 | TILInstil Bio Inc | 624,339 | $42.0B | 3.48% | |
| 8 | DYNDyne Therapeutics Inc | 1,114,960 | $40.0B | 3.31% | |
| 9 | VRDNViridian Therapeutics Inc | 1,678,207 | $38.2B | 3.16% | |
| 10 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $35.2B | 2.91% | |
| 11 | SLNSilence Therapeutics PLC | 1,105,454 | $20.1B | 1.66% | |
| 12 | ZBIOZenas Biopharma Inc | 1,183,260 | $20.0B | 1.66% | |
| 13 | ERASErasca Inc | 6,756,756 | $18.4B | 1.53% | |
| 14 | OLMAOlema Pharmaceuticals Inc | 1,505,862 | $18.0B | 1.49% | |
| 15 | CATBUSDAstria Therapeutics Inc | 1,552,685 | $17.1B | 1.41% | |
| 16 | TRMLTourmaline Bio Inc. | 591,882 | $15.2B | 1.26% | |
| 17 | RZLTRezolute Inc | 2,797,704 | $13.6B | 1.12% | |
| 18 | ORICOric Pharmaceuticals Inc | 1,277,818 | $13.1B | 1.08% | |
| 19 | SERASera Prognostics Inc | 1,650,440 | $12.9B | 1.07% | |
| 20 | COGTCogent Biosciences Inc | 1,122,471 | $12.1B | 1.00% | |
| 21 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $11.6B | 0.96% | |
| 22 | CMPSCompass Pathway PLC | 1,608,000 | $10.1B | 0.84% | |
| 23 | CELCCelcuity Inc | 610,500 | $9.1B | 0.75% | |
| 24 | DCTHDelcath Systems, Inc. | 997,005 | $9.0B | 0.75% | |
| 25 | CRVSCorvus Pharmaceuticals Holdings | 1,497,268 | $7.9B | 0.65% | |
| 26 | RGLSRegulus Therapeutics Inc | 5,000,000 | $7.8B | 0.65% | |
| 27 | ALXOALX Oncology Holdings Inc | 4,034,522 | $7.3B | 0.61% | |
| 28 | CMPXCompass Therapeutics Inc | 3,556,023 | $6.5B | 0.54% | |
| 29 | IOBTIO Biotech Inc | 6,173,439 | $6.5B | 0.54% | |
| 30 | AVU0Adverum Biotechnologies, Inc. | 833,333 | $5.8B | 0.48% | |
| 31 | TRVITrevi Therapeutics Inc | 1,612,903 | $5.4B | 0.45% | |
| 32 | VSTMVerastem Inc | 1,538,461 | $4.6B | 0.38% | |
| 33 | ENGNEngene Holdings Inc. | 678,705 | $4.5B | 0.37% | |
| 34 | CRBPCorbus Pharmaceuticals Holdings | 166,794 | $3.4B | 0.28% | |
| 35 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $2.3B | 0.19% | |
| 36 | ALLKGUSDAllakos Inc | 2,956,110 | $1.9B | 0.16% | |
| 37 | UNCYUnicycive Therapeutics | 4,470,152 | $1.8B | 0.15% | |
| 38 | ALGSAligos Therapeutics Inc | 141,879 | $1.2B | 0.10% | |
| 39 | CDXSCodexis, Inc | 388,144 | $1.2B | 0.10% | |
| 40 | DBVTDBV Technologies SA | 1,354,437 | $948.1M | 0.08% | |
| 41 | QTTBQ32 Bio Inc. | 20,559 | $917.3M | 0.08% | |
| 42 | TENXTenax Therapeutics Inc | 208,333 | $720.8M | 0.06% | |
| 43 | DTILPrecision Biosciences Inc | 4,675 | $41.9M | 0.00% |